thom w wrote:
Since there are currently viable vaccines available, including one that is fully approved, I wonder if it might be harder to get emergency approval for new ones. Obviously the emergency is not the same as it was. It would make sense to me, but I don't really have a position. I'm mostly just curious.
The protein subunit vaccines have the advantage of being stored at room temperature. Even though the U.S. is largely footing the bill, the vaccines will be used primarily in areas of the world that lack the technology to refrigerate the mRNA vaccines.